Informerics reaffirms IVR BBB-/ stable rating on Bliss GVS Pharma's long-term bank facilities
The rating of IVR A3 was assigned on company’s Short Term Bank Facilities.
Jan 13, 2021 11:01 IST India Infoline News Service
The rating of IVR A3 was assigned on Short Term Bank Facilities - Bill Discounting Rs40cr, Short Term Bank Facilities - Letter of Credit Rs15cr and Short Term Fund Based Facility - Bill Discounting Rs10cr.
IVR A3 was also assigned on Short Term Fund Based Facility - PCFC Rs10cr, Short Term Non-Fund Based Facility - Letter of Credit/Bank Guarantee Rs11cr and (Proposed) Short Term Non-Fund Based Facility - Letter of Credit/Bank Guarantee Rs4cr.
Bliss GVS Pharma Ltd ended at Rs205.60 per piece up by Rs0.95 or 0.46% on the BSE.
